Literature DB >> 32562216

Prognostic Significance of Granuloma and Amyloid Deposition in Nasopharyngeal Carcinoma.

Yi-Chan Lee1,2, Li-Yu Lee3,2, Ngan-Ming Tsang4,2, Cheng-Lung Hsu5,2, Li-Jen Hsin6,2, Tseng-Tong Kuo3, Kai-Ping Chang7,8.   

Abstract

The significance of granuloma and amyloid deposition in primary nasopharyngeal carcinoma (NPC) has yet to be investigated. This study aimed to evaluate their clinicopathologic associations. The histopathologic findings of 747 consecutive patients with primary NPC were retrospectively reviewed between January 2001 and December 2015. The presence of granulomas and amyloid deposits was observed in 68 (9.1%) and 62 (8.3%) patients, respectively. Granulomas were significantly associated with lower T classification, N classification, and overall TNM stage (p = 0.014, p = 0.006, and p = 0.001, respectively). Their presence was an independent predictor of overall survival (p = 0.033), disease-free survival (p = 0.034), and recurrence-free survival (p = 0.040). Conversely, amyloid deposition was not a predictor in any survival analyses. The present study demonstrated the prevalence of granuloma and amyloid deposition in the largest single institution cohort of primary NPC patients so far. Our results provide evidence that granulomas are significantly associated with better prognosis and treatment outcome. Further studies are needed to elucidate the mechanism of action of granuloma formation on the anti-tumor immunity of NPC.

Entities:  

Keywords:  Amyloid; Granuloma; Head and neck; Nasopharyngeal carcinoma; Radiotherapy

Year:  2020        PMID: 32562216      PMCID: PMC8010042          DOI: 10.1007/s12105-020-01194-4

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  24 in total

1.  Epithelioid granulomas in Hodgkin disease. A favorable prognostic sign?

Authors:  M J O'Connell; S C Schimpff; R H Kirschner; A B Abt; P H Wiernik
Journal:  JAMA       Date:  1975-08-25       Impact factor: 56.272

2.  Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.

Authors:  M Al-Sarraf; M LeBlanc; P G Giri; K K Fu; J Cooper; T Vuong; A A Forastiere; G Adams; W A Sakr; D E Schuller; J F Ensley
Journal:  J Clin Oncol       Date:  1998-04       Impact factor: 44.544

3.  Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses.

Authors:  A Leen; P Meij; I Redchenko; J Middeldorp; E Bloemena; A Rickinson; N Blake
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

4.  Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival.

Authors:  Jin-Ching Lin; Jian-Sheng Jan; Chen-Yi Hsu; Wen-Miin Liang; Rong-San Jiang; Wen-Yi Wang
Journal:  J Clin Oncol       Date:  2003-02-15       Impact factor: 44.544

5.  Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis.

Authors:  Takahiro Tsujikawa; Sushil Kumar; Rohan N Borkar; Vahid Azimi; Guillaume Thibault; Young Hwan Chang; Ariel Balter; Rie Kawashima; Gina Choe; David Sauer; Edward El Rassi; Daniel R Clayburgh; Molly F Kulesz-Martin; Eric R Lutz; Lei Zheng; Elizabeth M Jaffee; Patrick Leyshock; Adam A Margolin; Motomi Mori; Joe W Gray; Paul W Flint; Lisa M Coussens
Journal:  Cell Rep       Date:  2017-04-04       Impact factor: 9.423

6.  Florid granulomatous reaction in Epstein-Barr virus-positive nonendemic Burkitt lymphomas: report of four cases.

Authors:  Eugenia Haralambieva; Stefano Rosati; Carel van Noesel; Evan Boers; Marinus van Marwijk Kooy; Ed Schuuring; Philip Kluin
Journal:  Am J Surg Pathol       Date:  2004-03       Impact factor: 6.394

7.  Excessive epithelioid cell granulomatous reaction associated with a lymphoepithelial carcinoma (Schmincke-Regaud).

Authors:  W Wöckel; N Wernert
Journal:  Pathol Res Pract       Date:  1986-06       Impact factor: 3.250

8.  The pattern of amyloidosis in a Malaysian patient population.

Authors:  L M Looi
Journal:  Histopathology       Date:  1991-02       Impact factor: 5.087

9.  Sarcoid reaction: a rare occurrence associated to colon adenocarcinoma (case report and literature review).

Authors:  Cristina Díaz Del Arco; M Jesús Fernández Aceñero
Journal:  J Gastrointest Oncol       Date:  2016-08

Review 10.  [Sarcoidosis and sarcoid reactions in cancer].

Authors:  M Pavic; P Debourdeau; V Vacelet; H Rousset
Journal:  Rev Med Interne       Date:  2007-10-25       Impact factor: 0.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.